Sabrina Trudel

Final results of PX-171–003-A0, part 1 of an open-label, single-arm, phase II study of carfilzomib (CFZ) in patients (pts) with relapsed and refractory multiple myeloma (MM)

Sundar Jagannath, Ravi Vij, Keith Stewart et al. · Journal of Clinical Oncology · 2009 · 39 citations

Immunology, Refractory Mm Pts, Pathology +21

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study

Maxime Jullien, Sabrina Trudel, Benoît Tessoulin et al. · Annals of Hematology · 2019 · 33 citations

Hematological Malignancy, Single-agent Daratumumab, Medicine +4

The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma

Lina Benaniba, Benoît Tessoulin, Sabrina Trudel et al. · BMC Cancer · 2019 · 17 citations · Full text

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study

Sabrina Trudel, Benoît Tessoulin, Maxime Jullien et al. · Annals of Hematology · 2019 · 15 citations

Hematological Malignancy, Oncology, Hematology +7